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Abstract
 
Trypomastigotes, the highly motile infective forms of 
 
Trypanosoma cruzi,
 
 are capable of infecting
several cell types. Invasion occurs either by direct recruitment and fusion of lysosomes at the
plasma membrane, or through invagination of the plasma membrane followed by intracellular
fusion with lysosomes. The lysosome-like parasitophorous vacuole is subsequently disrupted,
releasing the parasites for replication in the cytosol. The role of this early residence within lyso-
somes in the intracellular cycle of 
 
T. cruzi
 
 has remained unclear. For several other cytosolic
pathogens, survival inside host cells depends on an early escape from phagosomes before lysoso-
mal fusion. Here, we show that when lysosome-mediated 
 
T. cruzi
 
 invasion is blocked through
phosophoinositide 3-kinase inhibition, a significant fraction of the internalized parasites are not
subsequently retained inside host cells for a productive infection. A direct correlation was observed
between the lysosomal fusion rates after invasion and the intracellular retention of trypomastigotes.
Thus, formation of a parasitophorous vacuole with lysosomal properties is essential for prevent-
ing these highly motile parasites from exiting host cells and for allowing completion of the in-
tracellular life cycle.
Key words: trypomastigote • invasion • intracellular • fusion • lysosome
 
Introduction
 
Chagas’ disease is a serious debilitating disease that affects
millions of people in Latin America. It is caused by infec-
tion with the protozoan parasite 
 
Trypanosoma cruzi
 
, which
is present in several vertebrate wild animals and is transmitted
by reduviid insects that inhabit human dwellings (1). The
infective forms of the parasite, trypomastigotes, are highly
motile and capable of invading several different cell types.
After invasion, trypomastigotes escape from the vacuole
into the cytosol, where they differentiate into amastigotes
and replicate (2).
Studies of the mechanism used by trypomastigotes to in-
vade nonphagocytic cells have revealed two distinct strategies.
The first one involves the induction of Ca
 
2
 
 
 
 signaling
through IP
 
3
 
 generation, recruitment and fusion of host cell
lysosomes at the parasite invasion site, and formation of a
parasitophorous vacuole with lysosomal properties (3–5). A
second pathway of entry involving the plasma membrane
was suggested by morphological studies (6) and was recently
characterized after inhibition of early lysosomal recruitment
and fusion by phosophoinositide (PI) 3-kinase inhibitors (7).
In cells treated with wortmannin or Ly294002, the lysosomal
entry pathway is abolished, but a reduced level of invasion is
still detected. These remaining parasites enter cells envel-
oped in vacuoles containing plasma membrane markers, by
a mechanism independent of host cell actin polymerization.
This population of parasitophorous vacuoles derived from
the plasma membrane also gradually acquires lysosomal
markers, through a unique maturation process that is not
blocked with PI 3-kinase inhibitors (7).
After entry into host cells, 
 
T. cruzi
 
 disrupts the lysosome-
like parasitophorous vacuole through the action of a low
pH-dependent lytic protein, and escapes into the cytosol
(8–11). During this transition, the parasites differentiate
into amastigotes, which are morphologically and antigenically
distinct from the invasive trypomastigotes and are capable of
replicating in the cytosol (2). Thus, 
 
T. cruzi
 
 trypomastigotes
can survive lysosomal fusion, an event that may actually fa-
cilitate their escape from the vacuole and differentiation
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into replicative amastigotes (10, 12, 13). In this respect, 
 
T.
cruzi
 
 differs markedly from other intracellular pathogens
such as 
 
Listeria monocytogenes
 
 and 
 
Shigella flexneri
 
, which also
disrupt the phagosome after cell entry and replicate free in
the cytosol. 
 
L. monocytogenes
 
 disrupts phagosomes shortly
after internalization, through the secretion of a low pH-
active pore-forming toxin, LLO (14, 15). When LLO is
mutated, 
 
L. monocytogenes
 
 cannot escape from the phagosome
or grow intracellularly (16). Similar observations were
made with 
 
S. flexneri
 
 IpaB mutants (17). These examples
have contributed to the view that avoiding lysosomal fu-
sion is advantageous for the survival of pathogens that are
adapted for growth in the cytosol. The fact that 
 
T. cruzi
 
 re-
sides for a significant period inside lysosomes before escap-
ing into the cytosol raises questions regarding the role of
lysosomal fusion in the life cycle. We set out to investigate
this issue, taking advantage of the identification of a plasma
membrane-mediated invasion pathway that does not in-
volve early lysosome recruitment and fusion (7). It was
conceivable that avoiding lysosomes during the initial entry
steps would favor intracellular survival, and lead to more
vigorous intracellular growth. Surprisingly, we found that
lysosomal fusion is critical for the intracellular retention and
subsequent replication of 
 
T. cruzi
 
. When early interaction
with lysosomes is inhibited, trypomastigote entry is revers-
ible and does not lead to productive infections. In contrast,
under normal conditions, the great majority of internalized
trypomastigotes survives the rapid fusion with lysosomes,
and subsequently replicates in the cytosol.
 
Materials and Methods
 
Antibodies and Reagents.
 
Anti–mouse and hamster Lamp1
mAbs (1D4B and UC1) were obtained from the Developmental
Studies Hybridoma Bank. The anti–rat Lamp1 mAb LY1C6 was
a gift from I. Mellman (Yale University, New Haven, CT). Anti–
 
T. cruzi
 
 polyclonal antibodies were generated by immunizing a
rabbit with 
 
T. cruzi
 
 trypomastigotes, and anti–Ssp-4 mAbs as de-
scribed previously (18). Anti–PI 3-kinase p85 polyclonal anti-
body was obtained from Upstate Biotechnology. Bovine brain
PIs, wortmannin, Ly294002, and cytochalasin D were obtained
from Sigma-Aldrich, protein G–agarose was obtained from Invit-
rogen, and [
 
32
 
P]-
 
 
 
-ATP (3,000 Ci/mmol, 10 mCi/ml) was ob-
tained from Amersham Biosciences.
 
Cells and Parasites.
 
Mouse murine embryonic fibroblasts
(MEFs) were prepared from day 13.5 mouse embryos (19) and
maintained in culture in high glucose DMEM (GIBCO BRL)
supplemented with 10% FBS, 1% penicillin-streptomycin, and 2
mM glutamine. Rat L6E9 and Chinese hamster ovary (CHO)
cells were maintained in DMEM and 
 
 
 
-MEM (GIBCO BRL),
respectively, containing 10% FBS, 1% penicillin-streptomycin
and 2 mM glutamine. Bone marrow–derived macrophages were
isolated from the femurs of 8–10-wk-old female BALB/c mice
(20) and cultured on 12-mm-diameter glass coverslips in six-well
tissue-culture plates at a density of 2.5 
 
 
 
 10
 
5
 
 macrophages per
well in 2 ml macrophage medium (RPMI 1640 containing 30%
L-fibroblast culture supernatant and 20% FBS).
Tissue culture trypomastigotes from the 
 
T. cruzi
 
 Y strain were
maintained in infected LLC-MK2 monolayers and purified as de-
scribed previously (3).
 
Cell Treatments.
 
MEF, CHO, or L6E9 cells were plated at
0.63 
 
 
 
 10
 
5
 
 cells/ml in media containing 10% FBS on 6-cm plas-
tic tissue culture dishes containing 12-mm round coverslips and
grown for 48 h at 37
 
 
 
C in a humidified atmosphere containing
5% CO
 
2
 
. 50 nM wortmannin or 50 
 
 
 
M Ly294002 was added to
cells for 30 min and 10 
 
 
 
M cytochalasin D was added for 15 min.
Both cell treatments were performed immediately before infec-
tion. In the case of Ly294002, the drug was kept in the medium
throughout the experiment.
 
T. cruzi Invasion Assay.
 
Infection of MEFs with purified try-
pomastigotes was performed for 15 min at 37
 
 
 
C at a multiplicity
of infection (MOI) of 50 (or 100 in Ly294002 experiments). In-
fection of CHO or L6E9 cells was performed for 30 min at an
MOI of 100. Drug-treated cells were rinsed with infection media
(DME 10% FBS) before incubation with parasites. In some exper-
iments, 
 
T. cruzi
 
 trypomastigotes were pretreated with 50 nM
wortmannin for 30 min at 37
 
 
 
C before incubation with mamma-
lian cells. Immediately after infection, cells were washed five times
with PBS to remove extracellular parasites, and either fixed in 4%
(wt/vol) paraformaldehyde/PBS overnight at 4
 
 
 
C or reincubated
with media for different times before fixation with paraformalde-
hyde. Macrophages were activated by treatment with 50 U/ml
IFN
 
 
 
 and 50 ng/ml LPS for 24 h, infected with 
 
T. cruzi
 
 trypo-
mastigotes at 37
 
 
 
C for 1 h at an MOI of 50, washed, and reincu-
bated at 37
 
 
 
C for 24 h. After fixation, coverslips with attached
cells were washed three times in PBS, incubated for 20 min with
PBS containing 2% BSA, and processed for an inside/outside im-
munofluorescence invasion assay as described previously (3). At
least 300 cells were analyzed per coverslip in triplicate.
 
Immunofluorescence and Video Microscopy.
 
After extracellular
parasite staining, cells were permeabilized with PBS/BSA con-
taining either 0.5% (MEFs), 0.2% (L6E9 cells), or 0.1% saponin
(CHO cells) for 20 min and incubated with a 1:50 dilution of hy-
bridoma supernatants producing the appropriate anti–Lamp1 an-
tibodies (mouse, rat, or hamster) or 5 
 
 
 
g/ml of the anti–Ssp-4
monoclonal antibody 2C2 (18) in PBS/BSA/saponin for 45 min.
After several washes with PBS/BSA/saponin, coverslips were in-
cubated for 30 min with a 1:250 dilution of the appropriate
FITC-conjugated affinity-purified goat IgG antibody (Molecular
Probes), mounted, and examined on a Ziess Axiovert 135 micro-
scope equipped with a Hamamatsu Orca II cooled CCD camera
controlled by Metamorph Software (Universal Imaging Corp.).
Time lapse images (2 frames/s) of trypomastigote invasion were
acquired with the same system on a heated microscope stage.
 
PI 3-Kinase Activity Assay.
 
To assay PI 3-kinase activity in
cell lysates, 9-cm dishes containing confluent MEFs were treated
or not with wortmannin as described before, washed with PBS,
and lysed in RIPA buffer (50 mM Tris-HCl, pH 7.4, 1% NP-40,
150 mM NaCl, 1 mM EGTA, 1 mM Na
 
3
 
VO
 
4
 
, 1 mM NaF, 0.5
mM PMSF, 0.7 
 
 
 
M pepstatin A, 0.1 mM chymostatin, 1.5 mM
 
 
 
-aminobenzamidine, 1 mM 
 
 
 
–aminobenzoic acid, 0.8 
 
 
 
M apro-
tinin, and 0.1 mM leupeptin) at different time points. Cell lysates
containing 400 
 
 
 
g of protein were incubated with 5 
 
 
 
g of anti-PI
3-kinase p85 antibodies for 1 h at 4
 
 
 
C under agitation, followed
by addition of 50 
 
 
 
l protein G–agarose and an additional incuba-
tion for 1 h. Immunoprecipitated proteins were washed twice in
RIPA buffer and divided into two fractions. One was resuspended
in 30 
 
 
 
l SDS-PAGE loading buffer and the other was washed
once and resuspended in 50 
 
 
 
l of kinase assay buffer (25 mM Tris-
HCl, pH 7.4, 10 mM Mg Cl2, and 120 mM NaCl). As a negative
control, RIPA buffer with no cell lysate was submitted to the
same process. The kinase assay was performed as described previ-
ously (21) with some modifications. 15 
 
 
 
g of bovine brain PIs, 
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100 
 
 
 
M of cold ATP, and 10 
 
 
 
Ci of [
 
32
 
P]-
 
 
 
-ATP were added to
the immunoprecipitated PI 3-kinase. The samples were incubated
at 37
 
 
 
C for 20 min, and the reaction was stopped by adding 300
 
 
 
l HCl 1N and 400 
 
 
 
l of 20 
 
 
 
g/ml PI in CHCl
 
3
 
. The organic
phase was transferred to a new tube, dried out, resuspended in 10
 
 
 
l CHCl
 
3
 
, and resolved by TLC followed by autoradiography.
 
Online Supplemental Material.
 
Video 1 depicts time-lapse mi-
croscopy of the 
 
T. cruzi
 
 invasion process and the initial period of
intracellular residence. Online supplemental material is available
at http://www.jem.org/cgi/content/full/jem.20041408/DC1.
 
Results
 
PI 3-Kinase-independent Invasion Leads to a Gradual Loss in
Internalized Parasites, a Process That Is Inversely Correlated with
the Acquisition of Lysosomal Markers.
 
When host cells are
treated with the PI 3-kinase inhibitor wortmannin, the ly-
sosome-mediated 
 
T. cruzi
 
 entry pathway is abolished and
the remaining invasion events detected appear to be medi-
ated exclusively by invagination of the plasma membrane
(7). To study the influence of this alternative, wortmannin-
resistant invasion pathway in the survival of 
 
T. cruzi
 
 inside
host cells, we investigated the fate of parasites after invasion
of MEFs. Confirming previous papers (7), pretreatment of
MEFs with wortmannin inhibited trypomastigote entry
(Fig. 1 A, 0 h) and the reduced number of parasites still able
to infect cells under these conditions was not detected in-
side Lamp1 positive compartments shortly after invasion
(Fig. 1 B, 0 h).
Surprisingly, when wortmannin-treated cells were ex-
amined a few hours after infection, the number of internal-
ized parasites was further reduced when compared with
untreated cells (Fig. 1 A, 5 h). The few remaining intracel-
lular parasites at these later time points were all located in
Lamp1 positive vacuoles, similar to what is observed in un-
treated cells (Fig. 1 B, 5 h). A time course in which cells
were examined at increasing intervals after infection re-
vealed that the progressive loss of intracellular parasites
caused by wortmannin treatment is fast, being already de-
tected 15–30 min after infection. In contrast, in untreated
MEFs, a constant number of intracellular parasites was de-
tected from 15 to 60 min after infection (Fig. 1 C). In these
cells, most parasitophorous vacuoles acquired Lamp1 rap-
idly; most likely in this case there is a contribution of the
early recruitment of lysosomes that occurs during the inva-
sion process (Fig. 1 D). In wortmannin-treated cells, on the
other hand, there was a gradual increase in the percentage
Figure 1. The loss of intracellular T. cruzi after inhibi-
tion of lysosome-mediated entry is inversely correlated
with the kinetics of intracellular lysosomal fusion. MEFs
were pretreated or not with wortmannin or Ly294002,
infected with T. cruzi, fixed or further incubated for the
indicated periods of time, and processed for immunofluo-
rescent detection of intracellular parasites. (A) Intracellular
parasites at 0 or 5 h after infection of cells pretreated or not
with wortmannin. (B) Percentage of intracellular parasites
associated with the lysosomal marker Lamp1 at 0 and 5 h
after infection of cells pretreated or not with wortmannin.
(C) The number of intracellular parasites at increasing periods
after infection. (D) Percentage of intracellular parasites associ-
ated with Lamp1 at increasing periods after infection. (E) In-
tracellular parasites at 0 or 40 min after infection of cells
treated or not with Ly294002. (F) Percentage of intracellular
parasites associated with the lysosomal marker Lamp1 at 0
and 40 min after infection of cells treated or not with
Ly294002. The data in A–F correspond to the mean of
triplicates   SD. Asterisks indicate statistically significant
differences (P   0.05, Student’s t test) between wortmannin-
treated and untreated cells at the 0 h time point (*) or be-
tween wortmannin-treated cells at 0 h and at other time
points (**). 
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of vacuoles positive for Lamp1, reaching 100% at 
 
 
 
45 min
after infection (Fig. 1 D). Thus, the decrease in intracellular
parasites observed after PI 3-kinase inhibition was inversely
proportional to the rate of lysosomal fusion to the parasito-
phorous vacuoles. Parasite loss was no longer observed
once all parasites were inside Lamp1 positive compart-
ments, suggesting that lysosomal fusion plays an important
role in retaining trypomastigotes inside host cells for a pro-
ductive infection. Very similar results were obtained in ex-
periments in which the MEFs were treated with a different
PI-3 kinase inhibitor, Ly294002 (Fig. 1, E and F).
To rule out the possibility that residual wortmannin re-
maining in the dish after host cell treatment was adversely
affecting the parasites, 
 
T. cruzi
 
 trypomastigotes were prein-
cubated with the drug for 30 min, washed, and used to in-
fect MEFs. No change in the total number of intracellular
parasites was observed, up to 2 h after infection (Fig. 2 A).
These results indicate that the loss of intracellular parasites
is likely to result from an effect of wortmannin on host
cells, and not on the parasites. However, wortmannin
treatment does not cause toxic effects leading to MEF loss
because the cells remained well spread and attached to the
coverslips for at least 4 h after treatment (Fig. 2 B).
The reduction in intracellular parasites after treatment
with wortmannin was not exclusive of MEFs; the same was
seen when two cell lines, L6E9 rat myoblasts and CHO
cells, were submitted to the same treatment and infection
protocol and assayed for trypomastigote persistence inside
cells. In both cases, pretreatment of cells with wortmannin
not only reduced infectivity, but also decreased the number
of intracellular parasites over time (Fig. 2, C and D). Wort-
mannin treatment also nearly abolished the number of par-
asites associated with Lamp1 positive compartments shortly
after infection (Fig. 2, E and F, 0 h). Alternately, most of
the remaining intracellular parasites at 1 h after infection
were detected inside lysosomes (Fig. 2, E and F, 1 h). Thus,
in several cell types, when lysosome-mediated entry is
abolished, the only parasites detected intracellularly after
longer periods of incubation were the ones within vacuoles
that had subsequently fused with lysosomes. This finding
suggested that lysosomal fusion is required to retain 
 
T. cruzi
 
trypomastigotes inside host cells.
 
Parasite Loss Is Not Due to Intracellular Death, and Also Oc-
curs after Disruption of the Host Cell Actin Cytoskeleton.
 
A
close examination of the 4
 
 
 
,6-diamidine-2
 
 
 
-phenylindole
(DAPI)-stained nuclei and kinetoplasts of intracellular try-
pomastigotes did not provide any evidence that the reduc-
tion in parasite numbers observed in wortmannin-treated
cells was due to intracellular killing. At several time points
after infection, from 15 to 60 min, intracellular trypomas-
tigotes detected inside cells showed no signs of nuclear
degradation (Fig. 3 A), a feature that can be readily de-
tected when trypomastigotes are killed in activated macro-
phages (Fig. 3 B). In addition, the detection of partially in-
ternalized trypomastigotes (detected by a partial staining
pattern with anti–
 
T. cruzi
 
 antibodies) was significantly
more frequent in wortmannin-treated cells (Fig. 3, C–G).
These findings suggested that blocking lysosome-mediated
entry leads to a reversal of the internalization process, with
a fraction of the recently internalized parasites subsequently
exiting the host cells. This possibility was reinforced by the
fact that trypomastigotes remain actively motile for several
minutes after entering cells (Video 1, available at http://
www.jem.org/cgi/content/full/jem.20041408/DC1).
We reasoned that if trypomastigote-containing parasito-
phorous vacuoles were able to fuse with the plasma mem-
brane releasing the parasites, disruption of the cortical actin
cytoskeleton might modulate this process. We examined this
Figure 2. (A) Treatment of T. cruzi with a PI 3-kinase inhibitor does
not affect the number of intracellular parasites over time. Trypomastigotes
were pretreated with wortmannin before infection of MEFs, and the
number of internalized parasites was determined at 0 and 2 h after infec-
tion. (B) Inhibition of MEF PI 3-kinase does not lead to MEF loss. MEFs
were pretreated or not with wortmannin, infected with T. cruzi, fixed or
further incubated for 4 h, and stained with DAPI, and the total number of
MEFs in 60 microscopic fields (100 ) was determined. (C–F) Loss of
parasites after wortmannin treatment is also observed in other cell types.
L6E9 (C and E) and CHO cells (D and F) were pretreated or not with
wortmannin and infected with T. cruzi, and the number of internalized
parasites (C and E) as well as the percentage of those parasites associated
with Lamp1 (D and F) at 1 h after infection were determined. The data in
A–F correspond to the mean of triplicates   SD. Asterisks indicate statistically
significant differences (P    0.05, Student’s t test) between wortmannin-
treated and untreated cells at the 0 h time point (*) or between wortmannin-
treated cells at 0 h and at other time points (**). 
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possibility by treating MEFs or CHO cells with cytochalasin
D, exposing them to a short infection period with 
 
T. cruzi
 
trypomastigotes, and quantifying the number of intracellular
parasites immediately, or after 1 h of further incubation. Cy-
tochalasin D treatment did not significantly alter the infec-
tion levels of MEFs (Fig. 4 A), but in CHO cells this treat-
ment stimulated 
 
T. cruzi
 
 entry by almost threefold in relation
to untreated cells (Fig. 4 C) as reported previously (3). Inter-
estingly, similar to what is observed after wortmannin treat-
ment, most of the parasites that invaded cytochalasin
D–treated cells were not found in Lamp1 positive vacuoles
immediately after invasion (Fig. 4, B and D, 0 h). Moreover,
a marked reduction in the number of internalized parasites
was observed in the cytochalasin D–treated cells after the ad-
ditional incubation period. At 1 h after infection, 60–70%
less intracellular parasites were detected and, at this time, all
were inside Lamp1 positive compartments (Fig. 4, B–D, 1 h).
Consistent with the aforementioned data for wortmannin
treatment (Fig. 1, A and C), in untreated cells no differences
were seen in the number of intracellular parasites over time
(Fig. 4, A and C). Thus, disruption of the cortical actin cyto-
skeleton appears to promote trypomastigote invasion by fa-
cilitating invagination of the plasma membrane, a pathway
that favors their subsequent exit from cells.
 
In the Absence of Lysosomal Fusion, T. cruzi Invasion Is Re-
versible.
 
The aforementioned results suggest that in the ab-
sence of lysosomal fusion, 
 
T. cruzi trypomastigotes that enter
cells can subsequently return to the extracellular medium. If
this hypothesis is correct, and if trypomastigotes remained
viable after exiting cells, new invasion events should occur
with time. This was investigated by infecting wortmannin-
pretreated MEFs, washing out the extracellular parasites,
and reincubating the cells for increasing periods of time (up
to 24 h). In untreated cells, the number of intracellular para-
sites at each time point remained constant throughout the
24-h period (Fig. 5 A). This is consistent with the fact that
T. cruzi does not start replicating intracellularly until  24 h
after invasion (22), and confirms that the extracellular trypo-
mastigotes were effectively removed, not leading to a signif-
icant number of later invasion events. The pattern of associ-
ation with lysosomal markers in untreated cells was also as
predicted; the number of parasites in Lamp1 positive vacu-
oles increased initially and gradually decreased as a conse-
quence of the ability of trypomastigotes to disrupt the para-
sitophorous vacuole (Fig. 5 B and reference 23). These
results also show that in primary fibroblasts, T. cruzi resides
in a lysosomal compartment for a significantly longer period
when compared with cultured cell lines (10).
When the lysosome-mediated invasion pathway was
blocked with wortmannin, the loss in intracellular parasites
occurring during the first hour of incubation was gradually
reversed (Fig. 5 A). This was not a consequence of host cell
loss because the MEF numbers per coverslip remained con-
stant throughout the experiment (passage three MEFs do
Figure 3. PI 3-kinase inhibition does not cause intracellular
death, but leads to reversal of T. cruzi invasion. (A) Intact try-
pomastigotes inside a MEF 1 h after the cells were pre-
treated with wortmannin. The arrows point to the normal
nuclear morphology. (B) Intracellularly degraded trypo-
mastigote 24 h after infection of a macrophage activated
with IFN /LPS. The arrow points to remnants of the par-
asite’s nucleus; the altered, enlarged kinetoplast is adjacent.
(C) The number of partially internalized trypomastigotes
after infection of MEFs treated or not with wortmannin. The
data correspond to the mean of triplicates   SD. (D) Un-
treated MEFs with one extracellularly attached trypomastigote
(red) and one completely internalized trypomastigote (arrow-
head, green). (E, F, and G) Wortmannin-treated MEFs
with partially internalized trypomastigotes (the arrows
point to internalized portions, not stained by the extracellu-
larly added anti–T. cruzi antibody). Lysosomes were stained
with anti-Lamp1 antibodies (green), extracellular trypo-
mastigotes with anti–T. cruzi antibodies (red), and MEF
and trypomastigote DNA with DAPI (blue).Lysosomes Retain T. cruzi Inside Cells 1140
not replicate within 24 h) (Fig. 5 C). The increased num-
ber of intracellular parasites observed over time after wort-
mannin treatment was clearly due to recent infection by
extracellular trypomastigotes. Thus, parasites entering wort-
mannin-treated cells can exit back into the extracellular
medium and subsequently reinvade cells. This conclusion
is based on the fact that a significant fraction of the intra-
cellular parasites detected at the later time points colocal-
ized with Lamp1 (Fig. 6, B–D), retained the trypomasti-
gote morphology (Fig. 6 D), and did not express the
amastigote-specific surface antigen Ssp-4 (Fig. 6 F and ref-
erences 18, 24). The newly invaded trypomastigotes de-
tected in cells pretreated with wortmannin could have re-
entered through plasma membrane invagination followed
by lysosomal fusion or directly through the lysosome-
mediated pathway. Our finding that, after 24 h, MEFs re-
cover from wortmannin treatment reinforces the latter
possibility (Fig. 5 D).
In wortmannin-treated cells, many parasites negative for
Ssp-4 expression (trypomastigotes and intermediate forms)
were observed side-by-side with a few Lamp1 negative
amastigotes, which are easily recognizable by the markedly
distinct kinetoplast morphology (Fig. 6, B and F) and ex-
pression of Ssp-4 (Fig. 6 F). In contrast, in control cells,
most intracellular parasites were free in the cytoplasm (as
indicated by the lack of Lamp1 staining), showed the typi-
cal amastigote morphology (round cell body and bar shaped
kinetoplast) (Fig. 6 A), and expressed the amastigote-spe-
cific surface antigen Ssp-4 (Fig. 6 E). Given that the trypo-
mastigote–amastigote transition only occurs after the lyso-
some-like parasitophorous vacuole is disrupted, the presence
of Ssp-4 positive amastigotes clearly reflects invasion events
that occurred several hours before. The total number of
intracellular parasites remained approximately constant
throughout this critical transition, from lysosome-resident
trypomastigotes to cytosol-resident amastigotes (Fig. 5 A),
indicating that the great majority of internalized T. cruzi re-
sists lysosomal degradation.
Figure 4. Disruption of the cortical actin cytoskeleton also leads to reversal
of T. cruzi invasion. (A) The number of intracellular parasites in cytochalasin
D–treated MEFs at 0 and 1 h after infection. (B) Percentage of intracellular
parasites associated with Lamp1 in cytochalasin D–treated MEFs. (C) The
number of intracellular parasites in cytochalasin D–treated CHO cells.
(D) Percentage of Lamp1-associated parasites in cytochalasin D–treated
CHO cells. Cells were pretreated or not with cytochalasin D, infected
with T. cruzi, fixed or incubated for the indicated periods of time, and
processed for immunofluorescence and detection of intracellular parasites.
The data in A–D correspond to the mean of triplicates   SD. Asterisks
indicate statistically significant differences (P   0.05, Student’s t test) be-
tween wortmannin-treated and untreated cells at the 0 h time point (*) or
between wortmannin-treated cells at 0 h and at other time points (**).
Figure 5. In the absence of lysosomal fusion, trypomastigotes exit host
cells and reinfect at later time points. (A) Intracellular parasites at increasing
periods after infection. (B) Percentage of intracellular parasites associated
with Lamp1 at increasing periods after infection. MEFs were pretreated or
not with wortmannin, infected with T. cruzi, and washed, and the number
of intracellular parasites was determined. (C) The total number of MEFs
in 60 microscopic fields (100 ) was determined for the same experiment
shown in A and B. The data in A–C correspond to the mean of triplicates  
SD. Asterisks indicate statistically significant differences (P   0.05, Stu-
dent’s t test) between wortmannin-treated and untreated cells at the 0 h
time point (*) or between wortmannin-treated cells at 0 h and at other
time points (**). (D) PI 3-kinase activity in untreated or wortmannin-
treated MEFs. (1) Negative control (no cell lysate). (2) MEF lysates immedi-
ately after wortmannin treatment. (3) MEF lysates 24 h after wortmannin
treatment. (4) MEF lysates not treated with wortmannin. White lines indicate
that intervening lanes have been spliced out.Andrade and Andrews 1141
Discussion
In this paper, we identified a novel role for the early fu-
sion with host cell lysosomes seen during host cell invasion
by T. cruzi. Trypomastigotes enter host cells by two mech-
anisms, both of which involve an early interaction with
host cell lysosomes. The first mechanism to be character-
ized is mediated by a direct fusion of lysosomes with the
plasma membrane at the parasite’s attachment site, a process
that gradually gives rise to the parasitophorous vacuole (3).
Recently, a second mechanism was revealed after the lyso-
some-mediated entry pathway was abolished with PI
3-kinase inhibitors (7). The remaining trypomastigote in-
vasion observed in wortmannin-treated cells appears to in-
volve invagination of the plasma membrane, without
participation of the host cell actin cytoskeleton. Parasito-
phorous vacuoles formed by this alternative mechanism
initially contain plasma membrane markers and rapidly ma-
ture by fusing with lysosomes (7). Thus, both mechanisms
used by T. cruzi to enter host cells involve early fusion of
lysosomes with the parasitophorous vacuole.
The role of early lysosomal fusion in the parasite’s intra-
cellular cycle was unclear, in particular because most patho-
gens that subsequently replicate free in the cytosol are
known to avoid lysosomal fusion during invasion. Our
findings have clarified this issue by showing that fusion
with lysosomes is critical for retaining trypomastigotes in-
side host cells. This unexpected role of lysosomes was re-
vealed through an investigation of the intracellular fate of
parasites in wortmannin-treated cells. Precise quantification
of intracellular parasites allowed us to determine that trypo-
mastigotes can exit host cells shortly after invasion, and that
the gradual fusion of lysosomes with plasma membrane-
derived parasitophorous vacuoles counteracts this exit process.
In addition to PI 3-kinase inhibition, we found that dis-
ruption of the host cell actin cytoskeleton also favors trypo-
mastigote entry through a pathway that does not initially
involve lysosome recruitment. The enhancement in T.
cruzi invasion observed in some cell types after cytochalasin
D treatment was originally attributed to a facilitation in the
docking and fusion of lysosomes with the plasma mem-
brane (3). However, subsequent studies raised the possi-
bility that actin depolymerization might favor invasion
through plasma membrane invagination (6, 7). Our results
and those of a recent paper (25) support this view because
disruption of the actin cytoskeleton leads to invasion events
that generate Lamp1 negative parasitophorous vacuoles.
Here, we show that these invasion events are also revers-
ible, as indicated by the rapid loss of parasites from cyto-
chalasin D–treated infected cells. Interestingly, numerous
plasma membrane-enveloped trypomastigotes protruding
from cytochalasin D–treated cells have been observed (25),
confirming the increased capacity for plasma membrane de-
formation after disruption of the cortical cytoskeleton. The
protrusion events may have been generated directly during
invasion because partial staining of parasites with extracel-
lularly added antibody was observed (25). In the absence of
a cortical cytoskeleton barrier, another possibility is that
completely internalized trypomastigotes can return to the
cell surface and protrude, becoming enveloped by two lay-
ers of membrane: one from the original invasion vacuole
and one from the evaginated plasma membrane. Thus, cy-
tochalasin D–induced protrusion events are not likely to
correspond to an early step in the release of trypomastigotes
capable of reinfecting other cells, as observed in our work.
The ability of T. cruzi trypomastigotes to exit cells when
lysosomal fusion is delayed is consistent with our frequent
observation of partially internalized parasites in wortman-
nin-treated cells. It is conceivable that parasitophorous vac-
uoles formed by membrane invagination, in the absence of
direct lysosomal involvement, may not always pinch off
from the plasma membrane intracellularly. In this case, for
Figure 6. Intracellular parasites found at later time points in wortmannin-
treated cells correspond to recent reinternalization events. MEFs were
pretreated or not with wortmannin, infected with T. cruzi, washed to
remove extracellular parasites, reincubated for 24 h, and processed for
immunofluorescence. (A) After 24 h, only cytoplasmic amastigotes are
detected in untreated cells (arrowheads). (B–D) In cells pretreated with
wortmannin, recently internalized trypomastigotes inside Lamp1 positive
vacuoles are also present (arrows). Lysosomes were stained with anti-
Lamp1 antibodies (green), extracellular trypomastigotes with anti–T. cruzi
antibodies (red), and MEF and T. cruzi DNA with DAPI (blue). (E) After
24 h, all intracellular parasites in untreated cells express the amastigote-
specific surface antigen Ssp-4 (arrowheads). (F) In cells pretreated with
wortmannin, most intracellular parasites still do not express Ssp-4, con-
firming that they have recently entered the cells (arrows). Staining with
the Ssp-4–specific mAbs is shown (green), as is MEF and T. cruzi DNA
staining with DAPI (blue).Lysosomes Retain T. cruzi Inside Cells 1142
reversal of the process, trypomastigotes would just have to
slide back out of the cells. However, because a significant
number of the intracellular parasites totally exclude the ex-
tracellularly added antibody, it is also possible that the vac-
uole separates completely from the plasma membrane, in
which case reversal would require a fusion event. We con-
firmed that trypomastigotes originally located intracellularly
can be released back into the medium, by performing rein-
fection experiments. T. cruzi only starts replicating after the
invasive trypomastigotes escape from vacuoles into the cy-
tosol (10, 23) and differentiate into amastigotes (22), events
which occur  24 h after invasion. Therefore, a short infec-
tion period followed by extensive washes to remove extra-
cellular parasites allows a precise follow-up of the intracel-
lular differentiation process and of recent internalization
events occurring within this period. In untreated cells, we
found that practically all trypomastigotes that initially enter
cells escape from the vacuole and differentiate into amasti-
gotes. In contrast, when the lysosome-mediated entry
pathway is inhibited, fewer amastigotes are detected, and
several recent trypomastigote invasion events are seen. This
was evident through the detection of Lamp1 on parasito-
phorous vacuoles, and the lack of expression of amastigote-
specific markers by the parasites. Because extracellular
trypomastigotes in these experiments were effectively re-
moved several hours before, the recent invasion events
detected must have been derived from trypomastigotes
originally resident inside cells, which were released back
into the medium.
Together, our data indicate that T. cruzi trypomastigotes
are capable of entering host cells through invagination of
the plasma membrane, forming a “reversible” vacuole that
can release the parasites back into the extracellular medium.
Our results also indicate that this reversible entry process
can only occur before the parasitophorous vacuole fuses
with lysosomes. Thus, lysosomal fusion, either during entry
(3) or shortly after entry (7, 25), is a critical event for com-
pletion of the T. cruzi intracellular cycle, and the establish-
ment of a productive infection. This finding is consistent
with the remarkable resistance of T. cruzi to the lysosomal
environment, with practically 100% of the internalized try-
pomastigotes surviving inside cells for the subsequent 24 h.
Although other intracellular protozoa such as Toxoplasma
gondii (26) lose their active motility after host cell invasion,
T. cruzi trypomastigotes retain their vigorous undulating
movements intracellularly (Video 1). The attachment of ly-
sosomes to microtubules through molecular motors (27,
28) may explain why fusion of lysosomes with T. cruzi–
containing vacuoles is so effective in retaining these highly
motile parasites inside host cells.
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